SomaLogic, Inc.
NASDAQ:SLGC
2.1 (USD) • At close January 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Assets: | ||||
| Current Assets: | ||||
| Cash & Cash Equivalents
| 421.83 | 439.488 | 164.944 | 14.06 |
| Short Term Investments
| 117.758 | 218.218 | 39.954 | 31.495 |
| Cash and Short Term Investments
| 539.588 | 657.706 | 204.898 | 45.555 |
| Net Receivables
| 17.006 | 17.074 | 17.449 | 4.203 |
| Inventory
| 13.897 | 11.213 | 7.02 | 8.43 |
| Other Current Assets
| 9.873 | 5.097 | 1.158 | 1.579 |
| Total Current Assets
| 581.701 | 691.552 | 231.975 | 59.767 |
| Non-Current Assets: | ||||
| Property, Plant & Equipment, Net
| 19.564 | 9.557 | 3.913 | 5.707 |
| Goodwill
| 10.399 | 0 | 0 | 0 |
| Intangible Assets
| 16.7 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 27.099 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 19.01 | 4.993 | 6.402 | -5.707 |
| Total Non-Current Assets
| 65.673 | 14.55 | 10.315 | 5.707 |
| Total Assets
| 647.374 | 706.102 | 242.29 | 71.262 |
| Liabilities & Equity: | ||||
| Current Liabilities: | ||||
| Account Payables
| 16.794 | 15.089 | 7.064 | 3.02 |
| Short Term Debt
| 2.477 | 0.066 | 2.423 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 |
| Deferred Revenue
| 3.383 | 3.021 | 1.762 | 0 |
| Other Current Liabilities
| 20.678 | 11.109 | 6.548 | 5.884 |
| Total Current Liabilities
| 43.332 | 29.285 | 17.797 | 8.904 |
| Non-Current Liabilities: | ||||
| Long Term Debt
| 0 | 0 | 34.252 | 36.568 |
| Deferred Revenue Non-Current
| 31.732 | 2.364 | 3.415 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 9.752 | 62.429 | 0.909 | -36.568 |
| Total Non-Current Liabilities
| 41.484 | 64.793 | 38.576 | 36.568 |
| Total Liabilities
| 84.816 | 94.078 | 56.373 | 50.842 |
| Equity: | ||||
| Preferred Stock
| 0 | 0 | 0 | 0 |
| Common Stock
| 0.019 | 0.018 | 0.011 | 0.727 |
| Retained Earnings
| -608.07 | -498.913 | -411.366 | -358.351 |
| Accumulated Other Comprehensive Income/Loss
| -0.513 | -0.072 | -0.002 | 0 |
| Other Total Stockholders Equity
| 1,171.122 | 1,110.991 | 597.274 | 378.044 |
| Total Shareholders Equity
| 562.558 | 612.024 | 185.917 | 20.42 |
| Total Equity
| 562.558 | 612.024 | 185.917 | 20.42 |
| Total Liabilities & Shareholders Equity
| 647.374 | 706.102 | 242.29 | 0 |